Join Growin Stock Community!

普惠醫工6543.TW Overview

TW StockBiotech. & Medical
(No presentation for 6543)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

普惠醫工（6543）Overall Performance

普惠醫工（6543）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

普惠醫工（6543） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

普惠醫工（6543）Key Information

普惠醫工（6543）Profile

Perfect Medical Industry Co., Ltd. manufactures and sells health and medical supplies in Taiwan and internationally. It provides hemodialysis blood tubing sets, A.V. fistula needle sets, huber needle/winged needle sets, blood transfusion sets, safety infusion sets, safety extension sets, I.V. locks, and medical face masks, as well as disposable syringes. The company also offers its products under the PF brand in Asia, Africa, Europe, and South America. Perfect Medical Industry Co., Ltd. was founded in 1989 and is headquartered in Changhua, Taiwan.

普惠醫工（6543）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.14
PE Ratio (TTM)
13.05
Forward PE
-
PS Ratio (TTM)
1.00
PB Ratio
1.94
Price-to-FCF
13.76
METRIC
VALUE
vs. INDUSTRY
Gross Margin
28.71%
Net Margin
7.65%
Revenue Growth (YoY)
4.98%
Profit Growth (YoY)
22.81%
3-Year Revenue Growth
6.54%
3-Year Profit Growth
10.40%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.14
PE Ratio (TTM)
13.05
Forward PE
-
PS Ratio (TTM)
1.00
PB Ratio
1.94
Price-to-FCF
13.76
Gross Margin
28.71%
Net Margin
7.65%
Revenue Growth (YoY)
4.98%
Profit Growth (YoY)
22.81%
3-Year Revenue Growth
6.54%
3-Year Profit Growth
10.40%
default symbol

6543

普惠醫工

27.90D

1.08%

(0.01)

  • When is 6543's latest earnings report released?

    The most recent financial report for 普惠醫工 (6543) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6543's short-term business performance and financial health. For the latest updates on 6543's earnings releases, visit this page regularly.

  • Where does 6543 fall in the P/E River chart?

    According to historical valuation range analysis, 普惠醫工 (6543)'s current price-to-earnings (P/E) ratio is 18.8, placing it in the Reasonable zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • How much cash does 6543 have?

    At the end of the period, 普惠醫工 (6543) held Total Cash and Cash Equivalents of 330.92M, accounting for 0.27 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6543 go with three margins increasing?

    In the latest report, 普惠醫工 (6543) achieved the “three margins increasing” benchmark, with a gross margin of 28.56%%, operating margin of 9.04%%, and net margin of 7.83%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6543's profit trajectory and future growth potential.